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Abstract 
According to the new kidney disease improv-
ing global outcomes (KDIGO) guidelines, the
term of renal osteodystrophy, should be used
exclusively in reference to the invasive diagno-
sis of bone abnormalities. Due to the low sen-
sitivity and specificity of biochemical serum
markers of bone remodelling, the performance
of bone biopsies is highly stimulated in dialy-
sis patients and after kidney transplantation.
The  tartrate-resistant  acid  phosphatase
(TRACP) is an iso-enzyme of the group of acid
phosphatases,  which  is  highly  expressed  by
activated osteoclasts and macrophages. TRACP
in osteoclasts is in intracytoplasmic vesicles
that  transport  the  products  of  bone  matrix
degradation. Being present in activated osteo-
clasts, the identification of this enzyme by his-
tochemistry in undecalcified bone biopsies is
an excellent method to quantify the resorption
of bone. Since it is an enzymatic histochemical
method for a thermolabile enzyme, the temper-
ature at which it is performed is particularly
relevant. This study aimed to determine the
optimal  temperature  for  identification  of
TRACP in activated osteoclasts in undecalci-
fied  bone  biopsies  embedded  in  methyl-
methacrylate. We selected 10 cases of undecal-
cified  bone  biopsies  from  hemodialysis
patients  with  the  diagnosis  of  secondary
hyperparathyroidism. Sections of 5 μm were
stained to identify TRACP at different incuba-
tion temperatures (37º, 45º, 60º, 70º and 80ºC)
for 30 min. Activated osteoclasts stained red
and trabecular bone (mineralized bone) was
contrasted with toluidine blue.  This approach
also increased the visibility of the trabecular
bone  resorption  areas  (Howship  lacunae).
Unlike what is suggested in the literature and
in  several  international  protocols,  we  found
that the best results were obtained with tem-
peratures between 60ºC and 70ºC. For techni-
cal reasons and according to the results of the
present study, we recommended that, for an
incubation time of 30 min, the reaction should
be carried out at 60ºC. As active osteoclasts are
usually scarce in a bone section, the standard-
ization  of  the  histochemistry  method  is  of
great relevance, to optimize the identification
of these cells and increase the accuracy of the
histomosphometric results. Our results, allow-
ing an increase in osteoclasts contrast, also
support the use of semi-automatic histomor-
phometric measurements. 
Introduction 
Uremic patients present significant morbid-
ity of bone and mineral metabolism, which has
been associated with osteoporosis, bone frac-
tures,  vascular  calcification,  and  increased
mortality.  Some  abnormalities  can  be  found
since  early  stages  of  chronic  renal  failure
(CKD),  but  they  are  particularly  relevant  in
dialysis patients and after kidney transplanta-
tion.  Contrarily  to  what  observed  in  general
population, in uremic patients the biochemical
markers of bone remodelling have a low speci-
ficity and sensitivity in the diagnosis of bone
turnover. Many of these patients are anuric or
with severe CKD, not allowing the use of urine
markers of bone remodelling.
For these reasons, the undecalcified bone
biopsy is the method of choice for evaluation of
renal  osteodystrophy,
1,2,3 allowing  the  charac-
terization of bone remodelling, osteoide min-
eralization and bone volume (cortical and tra-
becular) as defined by the new “turnover, min-
eralization,  volume”  (TMV)  classification  of
kidney  disease  improving  global  outcomes
(KDIGO).
4
Resorption  activity  is  usually  much  more
difficult to quantify than all the other bone his-
tomorphometric  parameters,  because  osteo-
clasts are usually scarce in a bone section. For
this  reason,  the  standardization  of  a  histo-
chemistry method to optimize the identifica-
tion of active osteoclasts would be highly rele-
vant.  This was the objective of the present
investigation, based on the expression of acid
phosphatase by active osteoclasts.
Tartrate-resistant  acid  phosphatase
(TRACP)  belongs  to  the  acid  phosphatases
(AcP)  –  EC  3.1.3.2.  The  catalytic  activity  of
these enzymes target phosphoesters in acidic
environments.
5 TRACP is a cationic ferric gly-
coprotein with a molecular mass of about 35
kDa  and  a  monomeric  peptide  structure.
6
TRACP  expression  is  found  in  cells  of  the
mononuclear  phagocyte  system,  most  abun-
dantly in bone-resorbing osteoclasts, alveolar
macrophages and dendritic cells.
5
TRACP activity was first detected in the ruf-
fled  border  membrane.  Later  immunohisto-
chemical studies detected TRACP in intracellu-
lar vesicles but not in the ruffled border region.
However,  contradictory  results  were  found
using immunogold technique, showing strong
staining in both structures. There is an actual
agreement that TRACP is mainly produced and
secreted from osteoclasts during bone resorp-
tion.
5
TRACP has a binuclear iron center and, like
other metallo-proteins, catalyzes the formation
of reactive oxygen species (ROS),  compounds
with  the  ability  to  destroy  peptide  bonds.
7
These compounds are secreted by osteoclasts
participating  in  the  process  of  bone  matrix
degradation.
8
In general, ROS have been shown to stimu-
late osteoclastic bone resorption, both in vivo
and in vitro, and enhance recruitment of osteo-
clasts.
5
Both  ROS  generation  and  AcP  activity  of
TRACP use the redox active iron for the cataly-
sis. However, the AcP activity has an acidic pH-
optimum and ROS are generated in a neutral
PH. Single amino acid TRACP mutants that are
completely inactive as phosphatases maintain
the ability to produce ROS, suggesting that the
two  activities  are  functionally  independent.
5
Beck et al.
9 demonstrated that the AcP activity
of TRACP is inhibited by the substrate of ROS
generating activity and vice versa which con-
firm the use of the same active site.
TRACP is also responsible for dephosphoryla-
tion of bone phosphoproteins like osteopontin,
a protein involved in binding osteoclasts to the
bone  trabecula.
10 This  action  suggests  that
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TRAP is also involved in the regulation of bone
resorption. Osteoclasts, also through the secre-
tion of hydrochloric acid and proteases, degrade
bone matrix, mainly through the breakdown of
links of collagen type I.
11 The products of degra-
dation  of  bone  matrix  are  phagocytised  and
transported  intracellularly  by  intracytoplasmic
vesicles. TRACP is found in these vesicles sug-
gesting that the fragmentation of the material
occurs, not only extracellularly in Howship lacu-
nae, but also intracellularly.
7
The role of TRACP in bone metabolism has
been elucidated by TRACP knock-out and over
expressing mouse models. Both models exhib-
it  a  specific  bone  phenotype.  Mice  lacking
TRACP  have  mild  osteopetrosis  resultant  of
defective bone resorption.
12 Mice over express-
ing TRACP have increased bone resorption and
formation resulting in mild osteoporosis.
13
All these characteristics of TRACP make this
enzyme an important factor in the diagnosis of
renal osteodystrophy. 
The enzymatic method used in this study
belongs  to  the  category  of  intramolecular
rearrangements.  In  this  category,  an  initial
colourless soluble substrate, after hydrolysis,
undergoes a molecular rearrangement produc-
ing an insoluble coloured final product. The re-
arragement is due to the reaction of the sub-
strate with a diazonium salt (like pararosani-
line) forming a chromophore azo group allow-
ing the detection of the reaction.
14
Bancroft and Stevens
14 suggested a method
similar to that used in this study. The main dif-
ferences are the absences of tartaric acid and
manganese sulphate in the incubation solu-
tion, and the referred temperature at 37ºC.
The first publication of this method applied
specifically to undecalcified bone samples was
by Evans et al.
15 The method described differs
from ours, in the use of tartaric acid and incu-
bation time (1 h). Also, the referred tempera-
ture was 37ºC. TRACP is resistant to tartrate
while  other  enzymes  present  in  the  bone
(which  hydrolyze  the  same  substrate)  are
not.
16 The manganese has an activator effect
on TRACP.
17 The study of undecalcified bone
biopsies is done through various histochemi-
cal  methods  that  allow  the  evaluation  of
parameters such as the trabecular and cortical
areas/volumes,  bone  mineralization  and
osteoid  tissue,  the  trabecular  surface  with
deposits  of  aluminum  and/or  iron,  the
osteoblastic surface and activated osteoclasts.
18
Activated osteoclasts arise in small quantity in
a normal bone biopsy, and they are even absent
in many cases of adynamic bone, which makes
their  identification  particularly  difficult.  The
quantification of activated osteoclasts enables
the  determination  of  the  degree  of  bone
resorption,
19 becoming thus essential for the
study of bone metabolism. 
The  method  used  in  this  study  was  opti-
mized in the Laboratório de Morfologia Renal
of  the  Nephrology  Service,  Hospital  Curry
Cabral, Lisboa, Portugal for the study of unde-
calcified  bone  biopsy  embebbed  in  methyl-
methacrylate  (MMA).  This  study  aimed  at
determining  the  optimal  temperature  (at  a
fixed incubation time of 30 min) for the iden-
tification of TRACP in osteoclasts in undecalci-
fied bone biopsies and embedded in MMA.
Materials and Methods 
Undecalcified bone biopsies from 10 uremic
patients  with  the  diagnosis  of  secondary
hyperparathyroidism (due to the higher num-
ber of activated osteoclasts) were selected.
20
These biopsies were processed according to
the protocol of the Laboratório de Morfologia
Renal  of  the  Nephrology  Service,  Hospital
Curry Cabral:
21
fixation – 70% alcohol – 8 days at room tem-
perature (RT);
dehydration – 96% alcohol – 24 h at RT, 100%
alcohol – 24 h at RT, acetone – 3 days at RT;
impregnation – impregnation solution – 3 days
at -20ºC;
polymerization – inclusion solution – 24 to 48
h at RT.
Both impregnation and inclusion solutions
had the same basis.
Solution A
MMA (Merck, Darmstadt, Germany); sodium
hydroxide  (BDH,  Poole,  England)  0.5N;  add
slowly  in  a  proportion  of  2MMA:1Sodium
hydroxide, well mixed and let it rest a few min
until the solution presented two phases. Then,
we reject the brown part in the bottom and kept
the  colourless  liquid.  This  procedure  was
repeated until the solution only presented one
phase, then stored at -20ºC for 24 hs.; we fil-
tered the solution and stored again at -20ºC.  
Solution B
Solution  A  –  300  mL;  benzoyl  peroxide
(Merck) – 2 g; Stored at -20ºC for 24 h, then fil-
tered and stored again at -20ºC.
Solution C
Solution  B  –  300  mL;  2-hydroximethylme  -
thacrylate (Merck) – 150 mL; polyethylenglycol
400 (Merck) – 50 mL.
Impregnation solution
Solution C – 15 mL; 5% NN-dimethylaniline
(BDH) in Isopropyl alcohol (Merck) – 90 μL.
Inclusion solution
Solution C – 15 mL; 5% NN-dimethylaniline
(BDH) in isopropyl alcohol (Merck) – 120 μL.
From each biopsy five sections of 5 μm were
performed. The sections were cut in a semi-
automatic microtome (Leica RM-2155, Wetzlar,
Germany) equipped with a tungsten blade, pro-
file d (Reichert-Jung, NY, USA). The sections
were placed on slides with Haupt’s gelatine.
Haupt’s gelatine was prepared by dissolving 1 g
of gelatine (Merck) in 100 mL of distilled water
at 55ºC and, after cooling, 15 mL of glycerol
(Merck)  and  2  g  of  phenol  (Merck)  were
added.
The slides were involved in a polyethylene
film and placed in a press in the incubator at
60°C for two days.
The MMA was not dissolved prior to staining
the sections.
Method of TRACP detection
The sections of each biopsy were incubated
at  different  temperatures  (37ºC,  45ºC,  60ºC,
70ºC and 80ºC) with the incubation solution in
a humid chamber for 30 min.
Incubation  solution:  i)  pararosaniline
(Merck) 4% (in hydrochloric acid 20%) – 1 mL;
ii) sodium nitrite (Merck) 3,75% - 3 mL; iii)
AS-TR  naphthol  phosphate  (Sigma-Aldrich,
Missouri,  USA)  1,6%  in  dimethylformamide
(Merck) – 2 mL; iv) 0.1 M acetate buffer pH5 –
20 mL; sodium acetate 0.1 M – 70 mL; acetic
acid  0.6%  -  30  mL  (always  confirm  the  pH
before use); v) manganese sulphate (Merck)
10% - 6 drops; vi) tartaric acid (Sigma-Aldrich)
- 260 mg.
The solution has to be filtered before adding
the tartaric acid.
This solution can be stored at -20ºC for sev-
eral months. Before use, the solution must be
kept at room temperature and filtered.
After washing with distilled water and dried
with  filter  paper  the  contrast  was  obtained
with toluidine blue (Sigma-Aldrich). After dry-
ing with filter paper, the slides were placed in
xylene and mounted with Entellan (Merck).
The  slides  were  observed  at  an  optical
microscope at the magnifications of 375x by
two of the authors without the knowledge of
case or temperature of the staining. 
The slides were classified as: ++ intensive-
ly stained, + stained, 0 unstained, +- stained
with  artefacts,  0-  unstained  with  artefacts.
Cases were the sections fell of the slides were
considered as NA (not applicable).  
The study was approved by the ethical com-
mittee of the Hospital Curry Cabral, and each
patient signed an informed consent form.
Results
As  expected,  activated  osteoclasts  stained
red (allowing to distinguishing certain cellular
characteristics such as multinucleation) and
trabecular bone stained blue. Activated osteo-
clasts stained with a red colour of high inten-
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sivity, which allows the performance of semi-
automatic bone histomorphometry.
Table 1 shows that at 37ºC and 45ºC there
was  in  all  cases,  an  absence  of  staining  of
osteoclasts. At 60ºC and 70ºC the results were
similar. These two temperatures provided the
best results.  
Figures 1 (60ºC) and  Figure 2 (70ºC) show
the strong staining of osteoclasts obtained at
both temperatures. At 80ºC the results were
variable. There were cases in which the sec-
tions fell from the slides. In other cases, at this
high temperature, it was observed a constant
presence of artefacts such as precipitation of
crystals  with  a  heterogeneous  staining  that
included  some  pale  areas  in  the  osteoclasts
cytoplasm, as shown in Figure 3.
Discussion 
Relevant bone abnormalities can be found
since  early  stages  of  chronic  renal  failure
(CKD). They are particularly relevant in dialy-
sis patients and after kidney transplantation.
The non-invasive diagnosis of bone turnover,
presents relevant limitations (lack of specifici-
ty and sensitivity). For these reason, the major
objective of our investigation was to determine
the bone formation and resorption, the bone
mineralization and bone volume in un-decalci-
fied bone biopsies (according to the TMV clas-
sification). The bone resorption activity is very
difficult to evaluate and quantify due to the
imbalance with bone formation. The measure-
ment of active resorption surface, number of
osteoclasts  and  eroded  surface  can  be  opti-
mized by a specific staining for osteoclasts, as
TRACP. 
The staining results at different tempera-
tures of 37ºC, 45ºC, 60ºC and 70ºC were homo-
geneous. 
At 80ºC there was no homogeneity, probably
because this temperature is close to the denat-
uration temperature of TRACP. Also, this tem-
perature seems to be too aggressive, since in
three cases occurred the loss of sections. 
The best results were obtained at 60ºC and
70ºC. However, at 70ºC in cases where sections
are  not  well  adherent  may  exist  the  risk  of
falling from slides. 
Compared  with  the  method  described  by
Bancroft and Stevens,
14 where the recommend-
ed temperature is 37ºC but with a very wide
time range from 15 to 60 min, our approach
and  results  are  clearly  different.  In  fact,  we
fixed the time of the reaction (in 30 minutes)
while  optimizing  the  temperature  of  the
process.
Also, comparing to the method presented by
Evans et al.,
15 there is a shortening of the reac-
tion time by increasing the temperature.
The reason why higher temperatures give
better and faster results is unclear and difficult
to explain, but the effects of the processing
and type of methacrylate used in enzymes may
explain it.
Given the small number of activated osteo-
clasts in bone biopsies of patients with normal
bone and, especially, in patients with adynam-
ic bone disease (which now represent about
40% of the dialyzed population), the identifica-
tion of TRACP expressed by these cells is cru-
cial for qualitative and quantitative diagnosis.
Standardizing the histochemistry reaction and
optimizing  the  bright  red  uniform  staining,
(but  keeping  intact  the  cellular  structure  of
osteoclasts) is particularly relevant when mak-
ing bone histomorphometry, either by manual
method or semi-automated method.
22
According to our results, we recommended
that for a time of 30 min, incubation should be
carried out at 60°C. At this temperature the
staining, identification and possible quantifi-
cation of osteoclasts, based on TRACP expres-
sion, are optimized. 
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